Cancer Immunotherapy: Building on Initial Successes to Improve...

2017-05-08T10:21:24-07:00

LONDON, April 12, 2017 /PRNewswire/ — This new report builds on our 2014 Insight Pharma Report, Cancer Immunotherapy: Immune Checkpoint Inhibitors, Cancer Vaccines, and Adoptive T-cell Therapies. In that report, ...